Deutsche Bank set a €87.00 ($101.16) price target on Sanofi (EPA:SAN) in a research note issued to investors on Thursday morning. The brokerage currently has a buy rating on the stock.

Other analysts also recently issued reports about the stock. Kepler Capital Markets set a €84.00 ($97.67) target price on shares of Sanofi and gave the company a buy rating in a research note on Friday, July 27th. Credit Suisse Group set a €80.00 ($93.02) target price on shares of Sanofi and gave the company a buy rating in a research note on Wednesday, August 1st. Societe Generale set a €90.00 ($104.65) target price on shares of Sanofi and gave the company a buy rating in a research note on Wednesday, August 1st. Citigroup set a €93.00 ($108.14) target price on shares of Sanofi and gave the company a buy rating in a research note on Friday, August 10th. Finally, Goldman Sachs Group set a €74.00 ($86.05) target price on shares of Sanofi and gave the company a neutral rating in a research note on Tuesday, July 31st. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of €78.22 ($90.96).

Shares of EPA:SAN opened at €66.17 ($76.94) on Thursday. Sanofi has a 12-month low of €63.09 ($73.36) and a 12-month high of €92.97 ($108.10).

Sanofi Company Profile

Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an oral immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Featured Article: How Do I Invest in Dividend Stocks

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.